Aveo CEO Tuan Ha-Ngoc to Interview Third Rock’s Mark Levin at Xconomy April 4 Biotech Forum
Mark Levin, co-founder of Boston’s Third Rock Ventures, is one of the nation’s premier life sciences investors. Tuan Ha-Ngoc, founder and CEO of Aveo Pharmaceuticals, is one of the country’s leading biotech executives.
Now, we are pleased to announce, the two will come together on April 4, when Ha-Ngoc will moderate a keynote chat with Levin at the Xconomy Forum: New England’s Emerging Biotech Stars. The event will take place a week from Wednesday at Biogen Idec’s headquarters in Kendall Square in Cambridge, MA.
The Levin chat is just one part of a star-studded afternoon designed to give you an extraordinary look into the future of New England biotech-and what is happening more generally in the field. The day will include another keynote from Biogen Idec CEO George Scangos, as well as special presentations from five of the region’s most promising biotech companies and executives:
Chip Clark, CEO, Genocea
Doug Fambrough, CEO, Dicerna
Tillman Gerngross, CEO, Adimab
Joanna Horobin, CEO, Syndax
Joseph Yanchik, CEO, Aileron
There’s a lot more besides that, including an R&D briefing from Biogen research boss Doug Williams and a panel on alternative financing for biotechs: Richard Winneker, senior VP of research for the Leukemia & Lymphoma Society was recently added to the lineup and will be one of four panelists passing on tips for winning grants from non-profits.
But getting back to the Levin chat, Ha-Ngoc reports the two know each other well, “so it will be a relaxed but substantive chat.” I, for one, am really looking forward to their conversation. The biotech industry is feeling a lot of pressure-especially when it comes to funding new startups-and Levin’s views on the field and how he approaches investing should be fascinating. We”ll set aside time for audience questions as well, so you can have your chance to ask about any issues they don’t address in the more formal chat.
Check out the full agenda and register here. We look forward to seeing you on April 4.